(VIANEWS) - Equity Lifestyle Properties (ELS), Collegium Pharmaceutical (COLL), Luxfer Holdings PLC (LXFR) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Equity Lifestyle Properties (ELS)
112% sales growth and 19.78% return on equity
Our company is a self-managed, self-administrated real estate investment trust (A "REITA") with its headquarters in Chicago.
Equity Lifestyle Properties's sales growth this year is anticipated to be 6.9% and 1.7% for next year.
Year-on-year quarterly revenue growth grew by 19.2%, now sitting on 1.28B for the twelve trailing months.
Volume
Today's last reported volume for Equity Lifestyle Properties is 1323880 which is 51.52% above its average volume of 873703.
Equity Lifestyle Properties's sales growth is a negative 0% for the present quarter and 112% for the next. The company's growth estimates for the present quarter and the next is 3.1% and negative 0%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 19.78%.
Volatility
Equity Lifestyle Properties's last day, last week, and last month's current intraday variation average was 4.08%, 2.31%, and 1.39%, respectively.
Equity Lifestyle Properties's highest amplitude of average volatility was 4.13% (day), 3.41% (last week), and 2.32% (last month), respectively.
Equity Lifestyle Properties's Stock Yearly Top and Bottom Value
Equity Lifestyle Properties's stock is valued at $77.28 at 20:22 EST, way under its 52-week high of $88.70 and way above its 52-week low of $67.50.
Equity Lifestyle Properties's Moving Average
Equity Lifestyle Properties's worth is above its 50-day moving average of $77.11 and under its 200-day moving average of $81.16.2. Collegium Pharmaceutical (COLL)
49.7% sales growth and 36.77% return on equity
Collegium Pharmaceutical, Inc., is a specialty pharmaceutical firm that develops and markets pain relief medicines.
Collegium Pharmaceutical's sales growth this year is anticipated to be 62.7% and 20.9% for next year.
Year-on-year quarterly revenue growth declined by 64.1%, now sitting on 276.87M for the twelve trailing months.
Volume
Today's last reported volume for Collegium Pharmaceutical is 192580 which is 53.68% below its average volume of 415795.
Collegium Pharmaceutical's sales growth for the next quarter is 49.7%. The company's growth estimates for the present quarter and the next is a negative 6.2% and 75.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 36.77%.
Volatility
Collegium Pharmaceutical's last day, last week, and last month's current intraday variation average was 0.45%, 2.05%, and 2.11%, respectively.
Collegium Pharmaceutical's highest amplitude of average volatility was 1.77% (day), 4.12% (last week), and 4.21% (last month), respectively.
Collegium Pharmaceutical's Stock Yearly Top and Bottom Value
Collegium Pharmaceutical's stock is valued at $17.65 at 20:22 EST, way under its 52-week high of $25.66 and above its 52-week low of $17.07.
Collegium Pharmaceutical's Moving Average
Collegium Pharmaceutical's value is below its 50-day moving average of $19.34 and way under its 200-day moving average of $19.88.3. Luxfer Holdings PLC (LXFR)
23.2% sales growth and 15.95% return on equity
Luxfer Holdings PLC is a material technology company that designs, produces, and delivers high-performance components and gas cylinders. These cylinders are used for transport, defence, emergency, and other industrial applications.
Luxfer Holdings PLC's sales growth this year is anticipated to be 14.3% and 5.8% for next year.
Year-on-year quarterly revenue growth grew by 20.2%, now sitting on 374.1M for the twelve trailing months.
Volume
Today's last reported volume for Luxfer Holdings PLC is 280447 which is 69.55% above its average volume of 165401.
Luxfer Holdings PLC's sales growth for the next quarter is 23.2%. The company's growth estimates for the present quarter and the next is a negative 8.3% and 56%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 15.95%.
Volatility
Luxfer Holdings PLC's last day, last week, and last month's current intraday variation average was 3.22%, 1.58%, and 1.30%, respectively.
Luxfer Holdings PLC's highest amplitude of average volatility was 4.15% (day), 3.90% (last week), and 3.04% (last month), respectively.
Luxfer Holdings PLC's Stock Yearly Top and Bottom Value
Luxfer Holdings PLC's stock is valued at $16.14 at 20:22 EST, way under its 52-week high of $23.91 and above its 52-week low of $15.34.
Luxfer Holdings PLC's Moving Average
Luxfer Holdings PLC's worth is below its 50-day moving average of $17.51 and way under its 200-day moving average of $19.18.4. Stepan Company (SCL)
19.2% sales growth and 13.37% return on equity
Stepan Company and its subsidiaries produce and sell specialty chemicals and intermediate chemicals for other manufacturers in North America and Europe. They are used in various products throughout North America, Europe and Latin America.
Stepan Company's sales growth this year is expected to be 7.3% and 2% for next year.
Year-on-year quarterly revenue growth grew by 23.3%, now sitting on 2.35B for the twelve trailing months.
Volume
Today's last reported volume for Stepan Company is 60360 which is 26.16% below its average volume of 81748.
Stepan Company's sales growth for the next quarter is 19.2%. The company's growth estimates for the ongoing quarter and the next is a negative 27.5% and 6.1%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.37%.
Volatility
Stepan Company's last day, last week, and last month's current intraday variation average was 0.59%, 0.78%, and 1.12%, respectively.
Stepan Company's highest amplitude of average volatility was 1.42% (day), 1.80% (last week), and 2.12% (last month), respectively.
Stepan Company's Stock Yearly Top and Bottom Value
Stepan Company's stock is valued at $99.56 at 20:22 EST, way below its 52-week high of $139.30 and higher than its 52-week low of $95.78.
Stepan Company's Moving Average
Stepan Company's worth is under its 50-day moving average of $102.43 and way below its 200-day moving average of $114.36.5. Comcast Corporation (CMCSA)
14.1% sales growth and 15.31% return on equity
Comcast Corporation is a global media and technology company.
Comcast Corporation's sales growth this year is anticipated to be 11.8% and 5.8% for next year.
Year-on-year quarterly revenue growth grew by 18.7%, now sitting on 113.76B for the twelve trailing months.
Volume
Today's last reported volume for Comcast Corporation is 35605500 which is 62.44% above its average volume of 21918300.
Comcast Corporation's sales growth for the next quarter is 14.1%. The company's growth estimates for the ongoing quarter and the next is 30.4% and 14.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 15.31%.
Volatility
Comcast Corporation's last day, last week, and last month's current intraday variation average was 4.88%, 3.01%, and 1.70%, respectively.
Comcast Corporation's highest amplitude of average volatility was 5.58% (day), 4.08% (last week), and 2.67% (last month), respectively.
Comcast Corporation's Stock Yearly Top and Bottom Value
Comcast Corporation's stock is valued at $39.70 at 20:22 EST, way below its 52-week high of $61.80 and higher than its 52-week low of $39.61.
Comcast Corporation's Moving Average
Comcast Corporation's value is way below its 50-day moving average of $46.46 and way under its 200-day moving average of $52.00.6. Bankwell Financial Group (BWFG)
12.2% sales growth and 14.05% return on equity
Bankwell Financial Group, Inc. is the bank holding company of Bankwell Bank. It provides a variety of banking services and products to Connecticut's commercial and residential customers.
Bankwell Financial Group's sales growth this year is expected to be 11.1% and 4.6% for next year.
Year-on-year quarterly revenue growth grew by 35.6%, now sitting on 72.7M for the twelve trailing months.
Volume
Today's last reported volume for Bankwell Financial Group is 10760 which is 44.52% below its average volume of 19395.
Bankwell Financial Group's sales growth for the next quarter is 12.2%. The company's growth estimates for the ongoing quarter and the next is 26.8% and 13.9%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 14.05%.
Volatility
Bankwell Financial Group's last day, last week, and last month's current intraday variation average was 1.43%, 0.42%, and 0.52%, respectively.
Bankwell Financial Group's highest amplitude of average volatility was 0.98% (day), 1.20% (last week), and 1.53% (last month), respectively.
Bankwell Financial Group's Stock Yearly Top and Bottom Value
Bankwell Financial Group's stock is valued at $32.90 at 20:22 EST, below its 52-week high of $35.34 and way above its 52-week low of $26.77.
Bankwell Financial Group's Moving Average
Bankwell Financial Group's value is under its 50-day moving average of $34.11 and above its 200-day moving average of $31.42.7. Columbia Banking System (COLB)
10.4% sales growth and 8.22% return on equity
Columbia Banking System, Inc. is the bank holding company of Columbia State Bank. It provides small- and medium-sized business services, as well as professional and individual banking services in Washington, Oregon, Idaho.
Columbia Banking System's sales growth this year is anticipated to be 6.7% and 107.2% for next year.
Year-on-year quarterly revenue growth declined by 0.5%, now sitting on 616.78M for the twelve trailing months.
Volume
Today's last reported volume for Columbia Banking System is 145492 which is 83.43% below its average volume of 878167.
Columbia Banking System's sales growth for the next quarter is 10.4%. The company's growth estimates for the current quarter and the next is a negative 28% and negative -13.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 8.22%.
Volatility
Columbia Banking System's last day, last week, and last month's current intraday variation average was 0.96%, 1.00%, and 1.78%, respectively.
Columbia Banking System's highest amplitude of average volatility was 1.93% (day), 2.77% (last week), and 3.22% (last month), respectively.
Columbia Banking System's Stock Yearly Top and Bottom Value
Columbia Banking System's stock is valued at $30.26 at 20:22 EST, way below its 52-week high of $45.05 and higher than its 52-week low of $29.22.